Offerpad's Q4 results fell short of analysts' estimates, with disappointing revenue, EBITDA, and EPS. The company's stock is down 1.1% and currently trades at $9.1 per share.
Despite promising growth forecasts, Offerpad Solutions' P/S ratio is significantly lower than most industry peers, which could indicate major risk factors putting downward pressure on its stock. Potential volatility in future revenues could be a concern for investors.
CraCra665 :
I go for the underdog. in most cases. I mean what I feel is right of course. I'm not goin to buy another couch when I have one. that being said ima spread it our but. I'm not gettin in when it's at a peak like that. just me tho.
オファーパッド・ソリューションズに関するコメント
Going to 11.00
コラムTop upgrades and downgrades on 6/21: XOM, ADBE, UAA, BEKE and more
• $ABMインダストリーズ(ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $アメリカン・タワー(AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $チャーチ・アンド・ドワイト(CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $チューイー(CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $センティーン(CNC.US)$ : Credit Suisse Upgrades to Outperform from...
コラムTop upgrades and downgrades on 3/30
• $ビーコン・ルーフィング・サプライ(BECN.US)$: JPMorgan Upgrades to Neutral from Underweight - PT $68
• $HFシンクレア(DINO.US)$ : Goldman Sachs Upgrades to Neutral from Sell - PT $43 (from $32)
• $フレッシュペット(FRPT.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $136
• $ヘルスエクイティー(HQY.US)$ : BTIG Upgrades to Buy from Neutral - PT $85
• $ホスト・ホテルズ・アンド・リゾーツ(HST.US)$ : Jefferies Upgrades to Buy from Hold - PT $25 (from $20)
• $マスコ・コーポレーション(MAS.US)$ : JPMorgan...
Red all over
$ChemoCentryx Inc(CCXI.US)$
$オファーパッド・ソリューションズ(OPAD.US)$
$ルート(ROOT.US)$
All not working for me tonight.
Not my night I guess.
まだコメントはありません